Top

Published in:

01-04-2018 | Invited Editorial

Pulmonary neuroendocrine carcinomas—evidence for a spectrum of differentiation

Author: Annikka Weissferdt

Published in: Virchows Archiv | Issue 4/2018

Excerpt

In this issue, Pelosi and colleagues present the results of a gene alteration analysis of a large series of pulmonary neuroendocrine carcinomas. This study provides molecular support for the concept that carcinoid tumors can transform into high-grade neuroendocrine carcinomas through the acquisition of additional molecular alterations. This concept challenges the current and widely held belief that carcinoid tumors are different histogenetic entities from the high-grade neuroendocrine carcinomas thereby denying the existence of any transitional forms. …

Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A (eds) (2015) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon

Gridelli C, Rossi A, Airoma G, Bianco R, Costanzo R, Daniele B, Chiara GD, Grimaldi G, Irtelli L, Maione P, Morabito A, Piantedosi FV, Riccardi F (2013) Treatment of pulmonary neuroendocrine tumours: state of the art and future developments. Cancer Treat Rev 39(5):466–472. https://doi.org/10.1016/j.ctrv.2012.06.012 CrossRefPubMed

Moran CA, Suster S, Coppola D, Wick MR (2009) Neuroendocrine carcinomas of the lung: a critical analysis. Am J Clin Pathol 131(2):206–221. https://doi.org/10.1309/AJCP9H1OTMUCSKQW CrossRefPubMed

Fernandez-Cuesta L, Peifer M, Lu X, Sun R, Ozretić L, Seidel D, Zander T, Leenders F, George J, Müller C, Dahmen I, Pinther B, Bosco G, Konrad K, Altmüller J, Nürnberg P, Achter V, Lang U, Schneider PM, Bogus M, Soltermann A, Brustugun OT, Helland Å, Solberg S, Lund-Iversen M, Ansén S, Stoelben E, Wright GM, Russell P, Wainer Z, Solomon B, Field JK, Hyde R, Davies MPA, Heukamp LC, Petersen I, Perner S, Lovly CM, Cappuzzo F, Travis WD, Wolf J, Vingron M, Brambilla E, Haas SA, Buettner R, Thomas RK (2014) Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids. Nat Commun 5:3518. https://doi.org/10.1038/ncomms4518 CrossRefPubMedPubMedCentral

Sampietro G, Tomasic G, Collini P, Biganzoli E, Boracchi P, Bidoli P, Pilotti S (2000) Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis. Appl Immunohistochem Mol Morphol 8(1):49–56. https://doi.org/10.1097/00129039-200003000-00008 PubMed

Peifer M, Fernández-Cuesta L, Sos ML, et al (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44(10):1104–1110. https://doi.org/10.1038/ng.2396 CrossRefPubMedPubMedCentral

Moran CA, Suster S (2000) Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases. Am J Clin Pathol 113(3):345–350. https://doi.org/10.1309/Q01U-60BL-VEV4-TWR1 CrossRefPubMed

Fabbri A, Cossa M, Sonzogni A, Bidoli P, Canova S, Cortinovis D, Abbate MI, Calabrese F, Nannini N, Lunardi F, Rossi G, La Rosa S, Capella C, Tamborini E, Perrone F, Busico A, Capone I, Valeri B, Pastorino U, Albini A, Pelosi G (2017) Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift. Virchows Arch 471(1):31–47. https://doi.org/10.1007/s00428-017-2130-2 CrossRefPubMed

Quinn AM, Chaturvedi A, Nonaka D (2017) High-grade neuroendocrine carcinoma of the lung with carcinoid morphology: a study of 12 cases. Am J Surg Pathol 41(2):263–270. https://doi.org/10.1097/PAS.0000000000000767 CrossRefPubMed

10.

Desmeules P, Sabari J, Santos-Zabala ML, Litvak AM, Pietanza MC, Poirier JT, Rudin CM, Klimstra DS, Travis W, Rekhtman N (2017) Metastatic lung carcinoid tumors: evidence of proliferation rate progression at metastatic sites. Mod Pathol 30:475A

Title: Pulmonary neuroendocrine carcinomas—evidence for a spectrum of differentiation
Author: Annikka Weissferdt
Publication date: 01-04-2018
Publisher: Springer Berlin Heidelberg
Published in: Virchows Archiv / Issue 4/2018
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-018-2308-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pulmonary neuroendocrine carcinomas—evidence for a spectrum of differentiation

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2018

Decidual granulomatous reaction in a placenta from a preeclamptic pregnancy: a case report and review of the literature

High immune cell score predicts improved survival in pancreatic cancer

In this issue

Minichromosome maintenance complex component 6 (MCM6) expression correlates with histological grade and survival in endometrioid endometrial adenocarcinoma

Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells